Vitde

Quick links to important sections

Vitde

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitde

What is Vitde?

Vitde is a pharmaceutical preparation of Colecalciferol, which is more commonly known as Vitamin D3. Vitamin D is a fat-soluble vitamin that plays a critical role in how the body absorbs and utilizes essential minerals, particularly calcium and phosphorus.

The Role of Vitamin D3

Vitamin D3 is naturally synthesized by the skin when it is exposed to ultraviolet B (UVB) sunlight. It can also be obtained through certain dietary sources, though it is found in relatively few foods. Once in the body, Colecalciferol undergoes chemical conversion in the liver and kidneys to become its active form, which acts as a hormone to regulate mineral balance.

Therapeutic Use

This medication is primarily used to manage the body's vitamin D levels. Its main functions include:

  • Bone Health: By facilitating calcium absorption in the intestines, it helps maintain the density and strength of the skeletal system.
  • Mineral Regulation: It ensures that the levels of calcium and phosphate in the blood remain within a healthy range, which is necessary for normal cell function and bone mineralization.
  • Supportive Care: It is often used as a supplement alongside specific treatments for bone density loss to ensure the body has the necessary building blocks for bone repair.

In individuals who cannot produce enough Vitamin D through sunlight or acquire it through diet, Vitde serves to restore and maintain adequate systemic levels.

What side effects are possible with Vitde?

Possible Side Effects and Safety Information

The safety profile of Vitde (Colecalciferol) is officially defined by the risks related to high mineral levels, primarily Hypercalcaemia (high blood calcium) and Hypercalciuria (high urine calcium), as documented in regulatory sources.

Officially Documented Adverse Reactions and Frequencies

Adverse reactions are classified according to frequency in official product labeling:

Frequency Classification Examples of Documented Effects
Uncommon (Affects < 1 in 100 people) Hypercalcaemia, Hypercalciuria
Rare (Affects < 1 in 1,000 people) Pruritus (itching), Rash, Urticaria (hives)

Serious reactions, which are typically extensions of hypercalcaemia, include severe organ damage. These are grouped under System-Organ Classes such as Renal and Urinary disorders (e.g., formation of kidney stones/nephrocalcinosis, kidney failure) and Cardiac disorders (e.g., irregular heartbeat).

Safety-Related Restrictions and Contraindications

The medicine is officially contraindicated (must not be used) in patients with specific pre-existing conditions, including:

  • Pre-existing high calcium levels (Hypercalcaemia or Hypercalciuria).
  • Hypervitaminosis D (excess Vitamin D in the body).
  • Severe Renal Impairment or a history of Nephrolithiasis (kidney stones).

Population-Specific Safety Notes

Official documents include specific safety considerations for vulnerable groups:

  • Severe Renal Impairment: Use is restricted as the medicine may not be metabolized normally.
  • Sarcoidosis: Caution and calcium monitoring are required due to increased sensitivity to the vitamin.
  • Pregnancy/Breast-feeding: High doses must be avoided, as Colecalciferol and its metabolites are excreted into breast milk, and prolonged hypercalcaemia can harm the foetus.

Overdose and Emergency Response

Overdose: When to Seek Help

Overdose of Vitde (Vitamin D) is officially documented by regulatory bodies as leading to Hypervitaminosis D, the primary consequence of which is severe Hypercalcaemia (excessively high calcium levels in the blood). The toxic effects and required emergency actions are strictly defined by this resulting hypercalcaemia.

Documented Overdose Manifestations

Symptoms and clinical signs associated with Vitde overdose, as listed in official prescribing information, include:anorexia (loss of appetite), nausea and vomiting, polyuria (increased urination), polydipsia (thirst), muscle weakness, fatigue, headache, and confusion or other mental disturbances.

Severe Outcomes and Emergency Actions

Severe or prolonged hypercalcaemia from overdose can progress to life-threatening conditions, including cardiac arrhythmia, irreversible renal impairment (kidney damage), and coma. Regulatory guidance strictly mandates the immediate discontinuation of Vitde and any calcium supplements upon suspicion of overdose. Management is primarily supportive, focusing on correcting the hypercalcaemia through measures like rehydration and the use of specific medications (e.g., bisphosphonates or calcitonin) under medical supervision, as no specific chemical antidote is documented.

Urgent Medical Attention Required

Immediate medical help must be sought if signs of severe hypercalcaemia or progression to serious organ damage—such as extreme lethargy, evidence of kidney problems, or changes in heart rhythm—are observed.

Therapeutic Uses of Vitde

Main Uses and Benefits of Vitde

Vitde is a therapeutic supplement containing Vitamin D3 (cholecalciferol), a fat-soluble vitamin essential for several physiological processes in the human body. Its primary function is to maintain mineral balance and support the structural integrity of the skeletal system.

Treatment and Prevention of Vitamin D Deficiency

The most common use of Vitde is to manage Vitamin D deficiency. This condition may arise due to inadequate sunlight exposure, poor dietary intake, or malabsorption issues. By restoring Vitamin D levels, the supplement helps prevent the clinical consequences of deficiency, such as bone pain and muscle weakness.

Support for Bone Health

Vitde plays a critical role in bone metabolism. It facilitates the absorption of calcium and phosphorus from the gastrointestinal tract, which are necessary for the mineralization of bone tissue.

  • Rickets: In children, Vitde is used to treat rickets, a condition characterized by softening and weakening of the bones.
  • Osteomalacia: In adults, it addresses osteomalacia, which involves the incomplete mineralization of the bone matrix.
  • Osteoporosis Management: Vitde is frequently used as an adjunct to specific osteoporosis treatments. It helps maintain bone density and reduces the risk of fractures, particularly in elderly populations or postmenopausal women.

Calcium Homeostasis

Beyond direct bone formation, Vitde helps regulate the concentration of calcium in the bloodstream. This balance is vital for the normal functioning of nerves, muscles, and various cellular processes. By ensuring adequate Vitamin D levels, the body can effectively manage its internal calcium stores.

Neuromuscular Function

Adequate levels of Vitamin D are associated with improved muscle strength and coordination. In older adults, the use of Vitde may contribute to better physical stability, which serves as a factor in reducing the frequency of accidental falls and subsequent skeletal injuries.

Regulatory References

  1. NIH MedlinePlus overview on Cholecalciferol

Eligibility and Restrictions for Use

Who Can and Cannot Use Vitde? (Official Regulatory Information)

Vitde (Colecalciferol) use is determined by pre-existing conditions and age, according to official regulatory labels.

Contraindicated Populations (Must Not Use)
Hypercalcaemia (high blood calcium levels)
Hypercalciuria (high urine calcium levels)
Hypervitaminosis D (high Vitamin D levels)
Severe Renal Impairment or a history of Nephrolithiasis (kidney stones)
Known Hypersensitivity to Colecalciferol or excipients (e.g., peanut/soya oil in some formulations)

Restricted and Conditional Use

Population Group Restriction or Caution
Children under 12 High-strength capsule forms are typically not recommended.
Pregnancy/Lactation Use is permitted for documented deficiency but high doses are not recommended; close monitoring is required to prevent overdose toxicity.
Sarcoidosis Use requires caution due to a risk of increased conversion of Colecalciferol to its active form.
Mild to Moderate Renal Impairment Requires caution and monitoring of calcium and phosphate levels.

Regulatory documents allow the use of Vitde for adults and adolescents with established deficiency or insufficiency, but the boundaries defined by hypercalcemia and severe kidney dysfunction represent absolute regulatory exclusions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interactions of Vitde (Colecalciferol) primarily involve substances that affect its metabolism, hinder its absorption, or modify mineral levels through pharmacodynamic effects. Interaction constraints are based strictly on regulatory findings, avoiding all therapeutic or dosing instruction.

Interaction Type Interacting Substances (Examples) Official Effect and Constraint
Altered Metabolism Certain Anticonvulsants (Phenytoin, Carbamazepine), Corticosteroids May increase Colecalciferol catabolism or impair metabolism, potentially leading to reduced effectiveness.
Impaired Absorption Bile Acid Sequestrants (Cholestyramine), Orlistat Physically block or chemically bind Colecalciferol in the intestine, reducing systemic exposure.
Additive Effects Thiazide Diuretics, Cardiac Glycosides (Digoxin) Increase the risk of hypercalcemia (Thiazides) or enhance toxicity risk by elevating serum calcium (Digoxin).

Administration Timing and Restrictions

Timing constraints are officially documented to mitigate reduced absorption. Co-administration with Bile Acid Sequestrants must be separated by at least four hours, and co-administration with Orlistat requires a separation of at least two hours. A formal restriction exists against combining Vitde with other high-dose Vitamin D or calcium supplements due to the significant, additive risk of hypervitaminosis D and hypercalcemia. Interaction effects, particularly concerning mineral levels, are noted as more clinically relevant in populations with impaired renal function.

Mechanism of Action

How Vitde Works: Mechanism of Action

Vitde's action is fundamentally based on a hormonal-like mechanism, which involves the controlled and sustained modulation of mineral metabolism and cellular processes throughout the body.

Gene-Level Signaling via VDR Activation

The drug's key action is mediated by its active metabolite binding to the Vitamin D Receptor (VDR), a nuclear receptor found in diverse tissues. This interaction acts as a molecular switch to directly influence gene expression, leading to the synthesis of specific proteins involved in systemic regulation.

Regulating Calcium and Phosphate Balance

This mechanism is applied in the pathway governing mineral homeostasis, primarily enhancing the small intestine’s ability to absorb dietary calcium and phosphate and influencing their handling in the kidney and bone. This targeted adjustment leads to the modulation of circulating mineral levels.

Modulating Extra-Skeletal Cellular Activity

Beyond mineral effects, Vitde modulates signaling patterns in extra-skeletal tissues, including cells of the immune system and those involved in cellular differentiation. This activity alters cellular responsiveness across multiple organs, contributing to the drug's overall physiological profile.

Dosage and Administration Information

How to Use Vitde: Official Administration Guidelines

Vitde, a Colecalciferol (Vitamin D3) preparation, is administered via the oral route. Its use is structured into distinct phases to ensure proper dose delivery and scheduling.


Standard Dosing and Frequency

The usage of Vitde generally involves two phases: an initial correction (or loading) phase and a long-term maintenance phase. Dosing regimens are structured as follows:

Usage Phase Typical Adult Dosing Range Frequency
Correction (Initial) 1,000 IU to 4,000 IU daily (for ~10 weeks) Daily
Loading (High-Dose) 50,000 IU (as an ampoule or capsule) Weekly (e.g., for 6 weeks)
Maintenance 1,000 IU to 2,000 IU Daily

Administration Requirements

Administration should adhere to specific guidelines to ensure effectiveness:

  • Timing with Food: Due to its fat-soluble nature, capsules and tablets should be swallowed whole with water, preferably taken with the main meal of the day.
  • Preparation: Liquid forms (oral solutions/drops) can be administered directly into the mouth or mixed with a small amount of food or liquid.
  • Missed Dose: If a daily dose is missed, the standard procedure is to skip the missed dose and take the next dose at the usual time; doubling the next dose is not recommended.
  • Duration: The initial correction phase is short-term (typically 6–10 weeks), after which treatment transitions to long-term maintenance therapy.

Specific considerations for high-risk populations (e.g., those with malabsorption or obesity) indicate these groups may require higher doses and close medical monitoring.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Vitde (Colecalciferol)

Evidence for Correcting Vitamin D Deficiency and Insufficiency

Vitde (Colecalciferol) was studied in Randomized Controlled Trials (RCTs) and observational cohorts focusing on its use for low Vitamin D levels. These efforts primarily monitored the concentration of 25-hydroxyvitamin D (25(OH)D) in the blood, which is the standard biomarker used to determine Vitamin D status. Studies included various populations, such as adults, older adults, infants, and children. The research describes a consistent pattern related to the ability of Colecalciferol supplementation to elevate the measured 25(OH)D biomarker levels. Findings generally described a transition in biomarker status from deficient to insufficient or sufficient. However, long-term studies have found mixed results when examining a direct link between this biomarker change and major long-term clinical outcomes across all populations.

Evidence for Bone and Mineral Homeostasis Disorders

The evidence base encompasses historical intervention trials and modern systematic reviews of Colecalciferol use in bone health. Research focused on conditions involving systemic or functional imbalance related to mineral metabolism. For severe deficiency conditions like Rickets in children and Osteomalacia in adults, research describes established patterns related to changes in the mineral imbalance, focusing on the normalization of blood markers and the healing of skeletal abnormalities.

Adjunctive Studies in Osteoporosis

In the context of Osteoporosis, studies explored the effect of Colecalciferol, often with calcium supplementation, in large RCTs and subsequent meta-analyses. Researchers examined the incidence of fractures and measurements of Bone Mineral Density (BMD) in populations consisting mainly of postmenopausal women and older men. The reports on fracture risk findings were mixed and heterogeneous across various large RCTs. Some studies described a pattern where fewer fractures were observed, particularly when Colecalciferol was co-administered with calcium.

Research Gaps and Areas of Uncertainty

A major source of uncertainty arises from the variability and inconsistency of findings, especially for non-skeletal endpoints. The variability in outcomes described in studies was often linked to the patient’s initial Vitamin D status and whether they also received calcium. Consequently, the independent, long-term impact of Colecalciferol on conditions beyond severe deficiency is still emerging, and research is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Vitde (FAQ)

Q: Are there any common foods or drinks to avoid while taking Vitde?

A: Official documents generally do not list specific foods or drinks, including alcohol, that are required to be avoided while using Vitde.

However, regulatory warnings caution against taking other supplements that contain high doses of calcium or Vitamin D. This is due to the potential for hypercalcaemia, which is a key safety consideration related to high blood calcium levels.


Q: Are there any long-term effects associated with using Vitde?

A: The main long-term concern associated with extended use or overuse of Vitde is the potential for hypercalcaemia (high blood calcium).

This condition can lead to serious issues over time, such as the development of kidney stones or soft tissue calcification. Official guidance describes that regular medical monitoring is important when considering long-term use.


Q: Does Vitde interact with common pain relievers like ibuprofen?

A: Formal drug interaction lists in regulatory documents for Colecalciferol do not typically name common non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.

The absence of this group of medicines from official interaction lists suggests that a direct metabolic or absorption interaction is not officially documented.


Q: Is Vitde safe for elderly patients?

A: Official regulatory documents do not contain specific restrictions or dosage adjustments based solely on advanced age.

Official cautions note that closer medical monitoring may be appropriate for elderly patients who are managing multiple other medications (polypharmacy).


Q: What if I have an allergic reaction to Vitde?

A: Allergic reactions are a possible but rare adverse event described in official product information. These signs can include hives (urticaria), rash, or itching (pruritus).

A serious allergic reaction, such as difficulty breathing or swelling of the face, tongue, or throat, is defined as a medical emergency.


Q: What happens if I accidentally take more Vitde than planned?

A: Taking more Vitde than planned, either acutely or chronically, carries the risk of hypercalcaemia (high blood calcium levels). Symptoms of this may include nausea, weakness, excessive thirst, and apathy.

Regulatory guidance recommends that all intake of Vitamin D should be stopped if an overdose is suspected.


Q: Are there any specific blood tests required when starting Vitde?

A: Official regulatory documents state that monitoring for serum calcium and phosphate levels is a necessary component of Vitde therapy.

This testing is critical to mitigating the risks of hypercalcaemia (high calcium) and hypercalciuria (high urine calcium) associated with the medicine.


Q: Is it okay to stop using Vitde suddenly?

A: Official guidance describes treatment as having an initial correction phase followed by a long-term maintenance phase, but it does not usually provide specific warnings about stopping abruptly.

If Vitde use is discontinued, a person’s Vitamin D levels will eventually decline, which may lead to the return of deficiency symptoms.


Q: Can I take Vitde if I have a history of liver problems?

A: While severe kidney impairment is a contraindication, liver issues are generally not listed as a major restriction. Regulatory documents state that no dose adjustment is typically required for patients with hepatic (liver) impairment.

However, some specific high-dose supplement warnings may caution against use in liver disease.


Q: Is it possible for Vitde to affect my sleep?

A: Sleep changes are not commonly listed as a direct side effect in regulatory documents.

However, some symptoms of hypercalcaemia, which can occur from high doses, may include general weakness or apathy. These systemic effects could potentially influence a person's overall well-being and sleep patterns.


Q: Is Vitde considered a controlled substance?

A: Colecalciferol (Vitde) is generally recognized as a fat-soluble vitamin.

According to regulatory scheduling systems, it is not classified as a controlled or habit-forming substance.


Q: Are there any known interactions between Vitde and herbal supplements?

A: Official regulatory warnings advise caution regarding potential interactions with certain herbal products.

Official warnings note that patients are typically advised to discuss the use of any herbal product with a healthcare provider before combining it with Vitde.


Q: What should I do if I feel dizzy after taking Vitde?

A: Dizziness is not listed as a common side effect in the official product information.

If severe dizziness or drowsiness occurs, especially along with other symptoms like an irregular heartbeat or confusion, it may be a sign of hypercalcaemia. The occurrence of such severe symptoms is a condition that requires immediate medical review.


Q: Is it normal to feel a change in appetite while taking Vitde?

A: Anorexia, or a loss of appetite, is listed in regulatory texts as a potential symptom of hypercalcaemia (high blood calcium).

This condition is a known risk associated with taking high doses of Vitde.


Q: How does Vitde affect my kidney function?

A: Vitde is contraindicated, meaning it must not be used, in cases of severe renal (kidney) impairment and in patients with a history of kidney stones (nephrolithiasis).

The official text indicates that the drug's metabolism is not normal in severe renal insufficiency.


Q: Is there a warning about using alcohol while on Vitde?

A: Official health information generally suggests that it is safe to consume alcohol while taking Colecalciferol.

Patients are reminded to follow general health advice and discuss the use of alcohol with a healthcare provider.


Q: Are there any warnings about driving or operating machinery while using Vitde?

A: Regulatory documents state that Vitde should not typically affect a person's ability to drive or operate machinery.

However, if a patient experiences any symptoms of hypercalcaemia, such as apathy or dizziness, it is noted that caution may be necessary.


Q: Can Vitde cause any mood changes?

A: Mood changes are not officially listed as a direct side effect.

However, apathy is noted as a symptom of hypercalcaemia, which is a known side effect of high-dose Vitde. Apathy is a mental state that can affect a person's mood.

How should Vitde be stored and disposed of?

Storage and Disposal of Vitde (Colecalciferol)

The official labeling mandates specific conditions to maintain Vitde's stability as a fat-soluble vitamin.

Storage Requirements

Vitde must be stored at Controlled Room Temperature, typically 20 C to 25 C, with excursions permitted up to 30 C. It is essential to protect the product from light and moisture and to avoid excessive heat and freezing. The medicine must be kept in its original container and the lid tightly closed after each use.

Safety and Disposal

All regulatory documents require that the product be kept out of the sight and reach of children. Unused or expired Vitde must be disposed of in accordance with local and national regulations and should not be discarded into household wastewater or sewers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitde found in:

A-Z Index: